#IDDF2023
Login
About IDDF
About IDDF
Named Lectures
Venue
e-Poster
e-Poster
Abstract
Call for Abstracts
Awards
Guidelines
About YIA
Case Report
Call for Case Reports
Awards
Guidelines
About Case/Video Champion
Programme
10 Jun
11 Jun
Speaker
Registration
Register
Accreditation
Visa
City Attractions
Conference
About IDDF
The Organizer
Venue
Partnership
Sponsors
Supporting Organizations
Registration Form
1
Main Programme
2
Accreditations
3
Order Summary
4
Confirmation
Speaker
Tiing-leong ANG
Changi General Hospital, Singapore
Duke-NUS Medical School, Singapore
National University of Singapore, Singapore
Nanyang Technological University, Singapore
Singapore
Tiing-leong ANG
Changi General Hospital, Singapore
Senior Consultant, Department of Gastroenterology and Hepatology
Head Research
Director of Digestive Diseases Centre
Duke-NUS Medical School, Singapore
Clinical Professor
National University of Singapore, Singapore
Adjunct Professor, Yong Loo Lin School of Medicine
Nanyang Technological University, Singapore
Adjunct Professor, Lee Kong Chian School of Medicine
Tiing-leong Ang is Senior Consultant of the Department of Gastroenterology and Hepatology, Head Research, and Director of Digestive Diseases Centre, at Changi General Hospital, Singapore. He is Clinical Professor at Duke-NUS Medical School and Adjunct Professor at Yong Loo Lin School of Medicine, National University of Singapore and Lee Kong Chian School of Medicine, Nanyang Technological University. He has subspecialty clinical interests in pancreaticobiliary diseases, image enhanced endoscopy, and advanced therapeutic endoscopy, in particular endoscopic resection of GI neoplasia, therapeutic ERCP and interventional EUS. His current research interests include the use of image enhancement technologies and artificial intelligence in endoscopy, pancreaticobiliary endoscopy, and the role of gut dysbiosis and changes in systemic metabolome in gastrointestinal diseases. He is Chairperson, Gastroenterology Residency Advisory Committee. He previously served as Chief, Department of Gastroenterology and Hepatology, Changi General Hospital, President of the Gastroenterological Society of Singapore, Chairperson of the Chapter of Gastroenterologists, Academy of Medicine, Singapore and Council Member of Academy of Medicine, Singapore.
Jakob BEGUN
Mater Research Institute, University of Queensland, Australia
Australia
Jakob BEGUN
Mater Research Institute, University of Queensland, Australia
IBD Group Leader
Associate Professor
Jakob Begun received his medical training at Harvard Medical School and his gastroenterology training at Massachusetts General Hospital. He returned to Australia to continue his work in clinical gastroenterology and translational research. He is the IBD Group Leader at Mater Research, the Director of Gastroenterology at Mater Hospital Brisbane, and an Associate Professor at The University of Queensland School of Medicine. He supervises a research laboratory housed in the Translational Research Institute which focusses on basic and translational research, and he performs clinical research at the Mater Research Institute and Mater Hospital, where he also oversees the IBD clinical trials program. His research interests include dissecting the functional genetics of inflammatory bowel disease, understanding the microbial drivers of health and disease, developing novel therapeutics for treating gut inflammation, and improving IBD clinical care through clinical research focused on responses to therapy and the use of non-invasive monitoring including intestinal ultrasound.
Zhaoxiang BIAN
Hong Kong Baptist University
Hong Kong
Zhaoxiang BIAN
Hong Kong Baptist University
Director of Clinical Division, School of Chinese Medicine
Associate Vice-President, Chinese Medicine Development
Zhaoxiang Bian had been educated in Nanjing University of Traditional Chinese Medicine (TCM), Beijing University of Traditional Chinese Medicine and Pharmacology and Guangzhou University of TCM, and was conferred the Ph.D. degree in Integrated Chinese and Western Medicine in 1994. After graduation, he engaged in clinical and basic research in digestive diseases in Guangzhou University of TCM. Under the Quality Migrant Admission Scheme of HKSAR, he moved to Hong Kong Baptist University in 2001. Prof Bian's research focuses mainly on the relationship between psychological stress and digestive diseases, especially focusing on the development and recurrence of irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colorectal cancer. Major research topics involve: i) Basic mechanism of visceral hyperalgesia and gastrointestinal motility disorder and its associated depression; 2) Psychological stress and colorectal cancer; 3) Clinical trial with Chinese medicine for digestive diseases, including IBS, IBD, functional constipation and colorectal cancer ; 4). New drug development based on Chinese herbal medicine and its active fraction for digestive diseases. He has been awarded second prize of National Science and Technology Award of China in 1999. Currently, Professor Bian serves as Director of Clinical Division, School of Chinese Medicine, and Associate Vice-President (Chinese Medicine Development) of HKBU.
Shannon CHAN
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Shannon CHAN
The Chinese University of Hong Kong, Hong Kong
Assistant Professor, Division of Upper Gastrointestinal & Metabolic Surgery
Shannon Chan is currently an Assistant Professor in the Division of Upper Gastrointestinal & Metabolic Surgery of The Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong in 2007. She completed general surgical training and received fellowships of the College of Surgeons of Hong Kong and Royal College of Surgeons of Edinburgh in 2014. Dr. Chan’s interest is in gastric and esophageal cancers, mainly focusing in the laparoscopic and robotic approach. She did her overseas training in National Cancer Centre in Tokyo, Yonsei University in Seoul and also Amsterdam Medical Centre in Amsterdam. Her research interests include upper gastrointestinal surgical oncology and advanced diagnostic and therapeutic endoscopy especially in interventional endoscopic ultrasound. She also has special interests in peritoneal surface malignancy and has started a multidisciplinary team for these rare, yet important group of patients. She is a member of the stomach and duodenal diseases subcommittee of the World Endoscopy Organisation (WEO) and is a reviewer for Digestive Endoscopy and Surgical Endoscopy. She has published over 20 peer-reviewed journals.
Apart from her research interest, Dr. Chan has also devoted herself to humanitarian aid work. In 2014, she joined the Médecins Sans Frontières (MSF, also named Doctors without borders). MSF is an international humanitarian non-governmental organization working in war-torn and under-developed regions. Dr. Chan joined their surgical missions to South Sudan from Oct 2016 - Dec 2016 and to Yemen from Dec 2019 to Feb 2020. After her return, she has further affirmed her commitment to providing humanitarian aid to the less developed parts of the world.
Chung-mo CHOW
Prince of Wales Hospital, Hong Kong
Hong Kong Children Hospital, Hong Kong
Hong Kong
Chung-mo CHOW
Prince of Wales Hospital, Hong Kong
Associate Consultant
Hong Kong Children Hospital, Hong Kong
Associate Consultant
Chung-mo Chow is a private paediatrician, who also works as a part-time Associate Consultant at Prince of Wales Hospital and Hong Kong Children Hospital, for providing paediatric gastroenterology services. He received his undergraduate training from the Chinese University of Hong Kong (CUHK) and obtained his paediatric fellowship in 2006. He also obtained the H. M. Lui Memorial Fund Fellowship in 2008 with oversea training in hepatology at Paediatric Liver Centre, King’s College Hospital, London. Afterwards, he had actively participated in the Hong Kong Society of Paediataric Gastroenterology, Hepatology and Nutrition (HKSPGHAN). From 2015 to 2019, he was the President of HKSPGHAN. Currently, he still serves HKSPGHAN as an Immediate Past President. As an Honorary Clinical Associate Professor of CUHK, Dr Chow also participated in research actively and published nearly 40 peer-reviewed articles in prestigious journals.
Hans CLEVERS
Universiteit Utrecht, The Netherlands
The Netherlands
Hans CLEVERS
Universiteit Utrecht, The Netherlands
Professor in Molecular Genetics
Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA. From 1991-2002 Hans Clevers was Professor in Immunology at the University Utrecht and, since 2002, Professor in Molecular Genetics. From 2002-2012 he was director of the Hubrecht Institute in Utrecht. From 2012-2015 he was President of the Royal Netherlands Academy of Arts and Sciences (KNAW).
From June 2015-2019 he was director Research of the Princess Máxima Center for pediatric oncology. Since March 2022, Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland.
Iris DOTAN
Rabin Medical Center, Petah Tikva, Israel
Israel
Iris DOTAN
Rabin Medical Center, Petah Tikva, Israel
Director of the Division of Gastroenterology
Iris Dotan is the Director of the Division of Gastroenterology at the Rabin Medical Center, Petah Tikva, Israel and is affiliated with the Sackler Faculty of Medicine, Tel Aviv, Israel. received her medical degree from the Sackler Faculty of Medicine and her postdoctoral fellowship was at the Immunobiology Center, Mount Sinai Medical Center, in New York, NY, where she focused on intestinal epithelial cell biology.
Clinical and research interests focus on biomarker-based stratification of patients with IBD and a personalized approach to their treatment and care, novel therapies, nutritional interventions, and patients with ulcerative colitis before and after restorative proctocolectomy, in a comprehensive, multidisciplinary pouch clinic.
Conducts translational research in mucosal immunology. She first described the anti-glycan antibodies and their relevance to Crohn's disease and investigates the role of glycans in intestinal immune responses.
The past president of the Israeli Association of Gastroenterology and Liver Diseases, the IOIBD chief, a member of the Scientific Committee of UEG, a member of UEG Equality and Diversity Task Force
Emad EL-OMAR
University of New South Wales, Sydney, Australia
GUT, Australia
Australia
Emad EL-OMAR
University of New South Wales, Sydney, Australia
Professor of Medicine
Director, UNSW Microbiome Research Centre
GUT, Australia
Editor in Chief
Emad El-Omar graduated in Medicine from Glasgow University, Scotland, and trained as a gastroenterologist. He worked as a Visiting Scholar/Scientist at Vanderbilt University, TN, and National Cancer Institute, MD, USA, and was Professor of Gastroenterology at Aberdeen University, Scotland, for 16 years before taking up the Chair of Medicine at St George & Sutherland Clinical Campus, University of New South Wales, Sydney, Australia. He is the Editor in Chief of the journal Gut. His research interests include all aspects of the microbiome, inflammation driven GI cancer and IBD. He is the Director of the UNSW Microbiome Research Centre at St George Hospital, Sydney.
Guadalupe GARCIA-TSAO
Yale University School of Medicine and the VA-Connecticut Healthcare System, USA
Clinical Core of the NIH-funded Yale Liver Center, USA
USA
Guadalupe GARCIA-TSAO
Yale University School of Medicine and the VA-Connecticut Healthcare System, USA
Professor of Medicine
Clinical Core of the NIH-funded Yale Liver Center, USA
Director
Guadalupe Garcia-Tsao is Professor of Medicine at Yale University School of Medicine and at the VA-Connecticut Healthcare System. She is Director of the Clinical Core of the NIH-funded Yale Liver Center.
Dr. Garcia-Tsao’s investigation focuses on cirrhosis, portal hypertension and related complications, having authored over two hundred original research publications in addition to several society guidelines and position papers in the field. Her H-index is 101.
Dr. Garcia-Tsao served as the President of the American Association for the Study of Liver Diseases in 2012 and has received numerous awards including the International Recognition Award (European Association for the Study of the Liver), the Distinguished Clinician Educator and Mentor Award (American Association for the Study of Liver Diseases) and the Distinguished Scientific Achievement Award (American Liver Foundation). She is currently Associate Editor for the New England Journal of Medicine.
Cesare HASSAN
Humanitas University, Italy
The European Society of Gastrointestinal Endoscopy, Italy
Italy
Cesare HASSAN
Humanitas University, Italy
Associate Professor
The European Society of Gastrointestinal Endoscopy, Italy
Chair of the Guideline Committee
Treasurer
Cesare Hassan, graduated in Medicine and Surgery in 1994, and he became a specialist in Gastroenterology and Digestive Endoscopy at ‘Sapienza University’ in Rome in 1998. His clinical and research turned mainly to the development of new approach for colorectal cancer screening, mainly focusing on clinical validation, cost-effectiveness and decision-making, as well as for prevention of upper GI-cancer, including endoscopic and medical treatment of pre-malignant gastric conditions and Barrett oesophagus. To date, his work has resulted in over 500 peer-reviewed publications, and is regularly invited to present at major national and international meetings. Dr. Hassan is currently the Treasurer of the European Society of Gastrointestinal Endoscopy, where he also served as Chair of the Guideline Committee, and he is Associate Professor of Gastroenterology at Humanitas University (Milan, Italy). His current research focuses on implementation of Artificial Intelligence for detection, characterization, and Quality Improvement of diagnostic endsocopy.
Akio Katanuma
Teine-Keijinkai Hospital
Tokyo Medical University
Japan
Akio Katanuma
Teine-Keijinkai Hospital
Director of Center for Gastroenterology
Tokyo Medical University
Visiting Professor
Akio Katanuma is currently the Director of Center for Gastroenterology, Teine-Keijinkai Hospital. He also currently serves as a Visiting Professor at the Tokyo Medical University.
Since then, he graduated Sapporo Medical University in 1991, he completed endoscopy training in the Muroran-city general hospital and Teine-Keijinkai hospital. His research has particularly focused on not only Endoscopic retrograde cholangiopancreatography (ERCP) but also EUS-guided fine-needle aspiration (EUS-FNA) and EUS-guided interventions, leading to more accurate and less invasive diagnostic and therapeutic procedures.
Dr. Katanuma is council member of The Japanese Society of Gastroenterology (JSGE), Japan Gastroenterological Endoscopy Society (JGES), Japanese Society for Abdominal Emergency Medicine, and Japan Pancreas Society (JPS). And he currently is one of the director of The Japan Biliary Association (JBA).
He served as an Associate Editor for Digestive Endoscopy, Journal of the Journal of Hepato-Biliary-Pancreatic Sciences, and Journal of Abdominal Emergency Medicine, and is in the editorial board Endoscopic ultrasound. He has published over 200 journal papers.
Christopher KHOR
Singapore General Hospital
Duke-NUS Medical School
Singapore
Christopher KHOR
Singapore General Hospital
Senior Consultant
Duke-NUS Medical School
Clinical Associate Professor
Christopher Khor’s main practice areas are in pancreato-biliary endoscopy, endoscopic resection and general gastroenterology. He has a keen interest in endoscopic quality and education, and in promoting collaboration among the regional endoscopy community. Dr Khor’s external work includes regular faculty invitations to regional centres to demonstrate and teach advanced endoscopy. Back home, Dr Khor led the project team that built his hospital's new Ambulatory Endoscopy Centre, a state-of-the-art facility which was inaugurated in 2017. He served as Director of the SGH Endoscopy Centres from 2013 to 2019, and as Chief of the SGH Department of Gastroenterology & Hepatology from 2015 to 2018. Dr. Khor is President of the GI-TAP Society, an Asia-Pacific group focused on EUS education and the engagement of women in endoscopy. He served as Vice-President of Asian-Pacific Digestive Week 2011 in Singapore, for which he directed the Endoscopy programme. Dr Khor is a past Chairman of the Chapter of Gastroenterologists, Academy of Medicine Singapore, and is a past President of the Gastroenterological Society of Singapore.
Jimmy LAI
Prince of Wales Hospital, Hong Kong
Hong Kong
Jimmy LAI
Prince of Wales Hospital, Hong Kong
Specialist in Gastroenterology and Hepatology, Department of Medicine and Therapeutics
Jimmy Lai graduated from the Chinese University of Hong Kong in 2015 with honours. He obtained MRCP(UK) in 2018 and received training in Gastroenterology and Hepatology in Prince of Wales Hospital. He obtained the fellowship of Gastroenterology and Hepatology in 2022.
Dr. Lai is active in liver diseases and hepatitis B research, and has published original research papers in peer-reviewed journals. He also has special interest in portal hypertension and endo-hepatology. With his research findings, he has presented in international hepatology conferences, was awarded Poster of Distinction Award in Asia Pacific Digestive Week Forum 2017, Prize for Best Original Research by Trainees in 2021 from Hong Kong Academy of Medicine, as well as Distinguished Research Paper Award for Young Investigators in 2019, Young Investigator Research Grant and Best Thesis Award (gold medal) in 2022 from Hong Kong College of Physicians.
Louis LAU
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Louis LAU
The Chinese University of Hong Kong, Hong Kong
Assistant Professor (Clinical), Department of Medicine & Therapeutics, Faculty of Medicine
Louis Lau graduated from Faculty of Medicine, The Chinese University of Hong Kong in 2012. He joined the Department of Medicine and Therapeutics in Prince of Wales Hospital after graduation. He obtained his specialist registration in Gastroenterology and Hepatology in 2019. He is currently serving as Assistant Professor in The Chinese University of Hong Kong.
Dr. Lau has special research interests in gastrointestinal bleeding and artificial intelligence with high impact publications in The New England Journal of Medicine, Gastroenterology, Gut and Gastrointestinal Endoscopy. He was nominated as a Distinguished Young Fellow of the Hong Kong Academy of Medicine. He received the Gold Medal of Best Thesis Award and the Distinguished Research Paper Award from the Hong Kong College of Physicians.
Dr. Lau is recognized as an advanced endoscopist internationally. He is a faculty member of the Asian Novel Bio-Imaging and Intervention Group (ANBIIG) and nominated as an Emerging Star of the World Endoscopy Organization. He received the Early Career Investigator Award from the Digestive Disease Week and the National Scholar Award from the United European Gastroenterology Week.
Joseph LIM
Yale University School of Medicine
USA
Joseph LIM
Yale University School of Medicine
Professor of Medicine
Director, Clinical Hepatology
Vice-Chief, Section of Digestive Diseases
Joseph Lim is a Professor of Medicine and Vice-Chief of the Section of Digestive Diseases at Yale University. He is a graduate of the Feinberg School of Medicine at Northwestern University (Chicago, Illinois, USA), and completed training in Internal Medicine at Yale University (New Haven, Connecticut, USA), and Gastroenterology/Hepatology at Stanford University (Palo Alto, California, USA). In his role at the Yale Liver Center, he conducts patient-oriented research evaluating clinical outcomes in chronic liver disease and runs an active clinical trials program examining novel investigational agents for viral hepatitis and NASH. He has held numerous leadership roles for the AASLD, AGA, and ACG, and served on the editorial boards of JAMA, Gastroenterology, Hepatology, and Gastrointestinal Endoscopy. He is the incoming Editor-in-Chief of Clinical Liver Disease, an online multimedia educational journal of the AASLD.
Shui-bin LIN
The First Affiliated Hospital, Sun Yat-sen University, China
Shui-bin LIN
The First Affiliated Hospital, Sun Yat-sen University, China
Executive Director, Center for Translational Medicine, Precision Medicine Institute
Principal Investigator
Shui-bin LIN received his Ph.D. degree in College of Medicine at University of Florida in 2012. After that he went to Boston Children’s Hospital/Harvard Medical School for his postdoctoral training at Prof. Richard Gregory’s lab. In 2017, Dr. Lin jointed the First Affiliated Hospital of Sun Yat-sen University in China as a principal investigator. He is interested in exploring the functions and mechanisms underlying mis-regulated RNA modifications in mRNA translation regulation and cancer progression. Dr. Lin has published more than 60 papers in journals including Nature, Nature Metabolism and Molecular Cell. He also serves as an Associate Editor for Molecular Therapy journal and works as Reviewer for multiple journals.
Chun-jen LIU
National Taiwan University College of Medicine and Hospital, Taiwan
Taiwan Association for the Study of the Liver, Taiwan
Taiwan
Chun-jen LIU
National Taiwan University College of Medicine and Hospital, Taiwan
Professor at the Department of Internal Medicine
Director of the Hepatitis Research Center and Clinical Trial Center
Taiwan Association for the Study of the Liver, Taiwan
President
Chun-jen Liu is a Professor at the Department of Internal Medicine, and Director of the Hepatitis Research Center and Clinical Trial Center, National Taiwan University College of Medicine and Hospital. He achieved his MD and PhD at the National Taiwan University. Professor Liu’s interests are in chronic hepatitis B and C, HCC, and nonalcoholic fatty liver disease, where his studies focus on the role of viral and host factors in the pathogenesis and treatment of chronic viral hepatitis, NAFLD and HCC. He has been actively involved in clinical trials for the treatment of various liver diseases, and delivered the JGH Foundation Emerging Leader Lecture in APDW 2013. Recently, he received NTUH outstanding Research Award 2022. He is now the President of the Taiwan Association for the Study of the Liver, and the associate editor of the Journal of the Formosan Medical Association and Journal of Microbiology, Immunology and Infection. He has authored 350 papers in international peer-reviewed journals.
Rohit LOOMBA
University of California San Diego, USA
USA
Rohit LOOMBA
University of California San Diego, USA
Professor of Medicine (with Tenure)
Chief, Division of Gastroenterology and Hepatology
Rohit Loomba is a Professor of Medicine (with tenure), Chief, Division of Gastroenterology and Hepatology, at the University of California at San Diego. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic steatohepatitis (NASH), and non-invasive assessment of liver disease using advanced imaging modalities.
Dr. Loomba is the founding director of the UCSD NAFLD Research Center which is one of the most well-funded clinical and translational research programs at UCSD. The NAFLD Research Center fosters collaborative team science where a multi-disciplinary team of researchers are conducting cutting edge research in all aspects of NAFLD including non-invasive biomarkers, genetics, epidemiology, clinical trial design, imaging end-points, and integrated OMICs using microbiome, metabolome and lipidome. This integrated approach has led to several innovative applications such as establishment of MRI-PDFF as a non-invasive biomarker of treatment response in early phase trials in NASH, which has now been adopted in more than 100 clinical trials conducted worldwide. He holds several patents on non-invasive biomarkers of NASH and fibrosis.
His research is funded by the National Institutes of Health as a Principal Investigator including two R01s, three U01 (two NIDDK and one from NIAAA), clinical core director of P30 (NIDDK) and project director P01 (NHLBI) grant mechanisms, Foundation of NIH, as well as several large multicenter, multi-million dollar investigator initiated research projects funded by the industry. He is the Principal Investigator, UCSD, for the NIDDK-sponsored NASH Clinical Research Network and the Liver Cirrhosis Network. He served as the elected Chair of the NAFLD, Special Interest Group of the American Association for the Study of Liver Diseases. He also serves as on the Scientific Advisory Board of numerous biotechnology and large pharmaceutical companies and guides clinical drug development and biomarker discovery programs globally.
He serves on the Editorial Board of Gastroenterology, Journal of Hepatology, GUT and Nature Reviews in Gastroenterology and Hepatology. He recently completed a 5-year term as the Deputy Editor of HEPATOLOGY, the official journal of the AASLD. Currently, he serves as the co-Editor of Alimentary Pharmacology and Therapeutics, an international journal in the field of gastroenterology and Hepatology. Dr. Loomba has published more than 425 manuscripts and has an H-index of 116. He has been consistently listed among the top 1% of the globally highly cited scientists across all fields in 2019, 2020, 2021 and 2022 by Web of Science. He is an elected member of the American Society of Clinical Investigation (ASCI), and the Association of American Physicians (AAP).
Brigette MA
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Brigette MA
The Chinese University of Hong Kong, Hong Kong
Professor, Department of Clinical Oncology
Honorary Consultant, Department of Clinical Oncology
Brigette Ma is currently Professor (CA2) and Honorary Consultant at the Department of Clinical Oncology, Chinese University of Hong Kong (CUHK), Medical Director of the Phase I Clinical Trial Centre (Oncology), Co-Director of the Cancer Drug Testing Unit and Chair of the NTEC-CUHK ethics committee for phase 1 studies. She received her undergraduate degree with Honours at Monash University, Australia, and was awarded Fellow of the Royal Australasian College of Physicians, Fellow of Hong Kong College of Physicians, and Doctor of Medicine (CUHK). She underwent training in Medical Oncology at the Peter MacCallum Cancer Institute, Melbourne, and was Research Fellow at the Princess Margaret Hospital, Toronto, Canada. She has published over 200 peer-reviewed papers. Notably, she had been a Faculty member of the European Society of Medical Oncology (ESMO) in Gastrointestinal Cancer, and was a member of the Consensus Working Group for the management of metastatic colorectal cancer; executive member of the National Cancer Institute (Bethesda, USA) Head and Neck Cancer Steering Committee - Clinical Trials Planning Group on Nasopharyngeal Cancer, Co- chair of Widely Metastatic Group; and mentor and committee member of the Women in Cancer Research of the American Association of Cancer Research. Her other current roles included: member of the Joint Scientific Committee for Phase 1 Clinical Trials, Centre of Health Protection, Hong Kong Hospital Authority; Track Chair/ member of the Scientific Committee American Association of Cancer Research, ESMO congresses. She is co-Scientific chair of ESMO (Asia) conference in Singapore and co-chairs for some ESMO advanced course/ workshops concerning biomarker/ precision medicine and early drug development
Christian MAASER
Hospital Luenburg
International Bowel Ultrasound (IBUS) Group
Germany
Christian MAASER
Hospital Luenburg
Acting Chair of the Internal Medicine Department
Head of the Department of Geriatrics
International Bowel Ultrasound (IBUS) Group
Founding Members
Chair
Christian Maaser leads the IBD center, is acting chair of the Internal Medicine Department Hospital Luenburg and head of the Department of Geriatrics in Germany. He received his medical education at the University Marburg and Hamburg as well as in New York and Johannesburg. He went on to complete his Internal Medicine and Gastroenterology training at the University of Muenster and spent 2 years as post-doc in the Laboratory for Mucosal Immunology at the University of California, San Diego. He is one of the founding members and the current chair of the International Bowel Ultrasound (IBUS) group, is a current member of the ECCO educational committee and of the ECCO congress 2022 organizing committee. He has been member of various national and international IBD guideline committees. One of his major research focuses is to explore the role of intestinal ultrasound in monitoring IBD.
Joyce MAK
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Joyce MAK
The Chinese University of Hong Kong, Hong Kong
Honorary Clinical Assistant Professor in Department of Medicine and Therapeutics
Joyce Mak is a Specialist in Gastroenterology and Hepatology. She graduated from the University of Hong Kong and became fellow in gastroenterology in 2015. She is passionate about inflammatory bowel disease (IBD) and she further pursuit training in IBD in St Mark’s Hospital, London and University of Chicago. She has been working on various projects in IBD and gut microbiota. She has published 3 book chapters on IBD and more than 40 peer-reviewed journal articles, including Gut, Lancet Gastroenterology and Hepatology. She is currently the vice president of the Hong Kong IBD Society and the Honorary Clinical Assistant Professor in Department of Medicine and Therapeutics at the Chinese University of Hong Kong.
Lung-Yi MAK
The University of Hong Kong, Hong Kong
Hong Kong
Lung-Yi MAK
The University of Hong Kong, Hong Kong
Clinical Assistant Professor
Lung-yi MAK is a Clinical Assistant Professor at the University of Hong Kong. She completed her specialty training in year 2018 in Queen Mary Hospital Hong Kong as a gastroenterologist and hepatologist, and is conferred the degree of Doctor of Medicine by HKU in year 2021. Dr Mak’s research interests include clinical and translational research of liver diseases, especially in the field of chronic viral hepatitis, fibrosis assessment and non-alcoholic fatty liver disease. She has published more than 100 peer-reviewed articles in reputable journals, with >50 being first-authored/ co-first authored articles. Dr Mak has received numerous academic awards, and was granted the Croucher Foundation Fellowship for 2021/2022.
Helmut MESSMANN
University Hospital Augsburg, Germany
Germany
Helmut MESSMANN
University Hospital Augsburg, Germany
Director of the Department of Internal Medicine
Helmut Messmann is the Director of the Department of Internal Medicine at University Hospital Augsburg in Germany and Head of the largest Interventional Endoscopy Center in Germany. His focus is on gastrointestinal oncology, intensive care medicine and interventional endoscopy. He was the President of ESGE from 2021-2023 and is General Secretary of the DGVS and was president of the Germany Society of Intensive Care Medicine.
Professor Messmann is one of Europe’s leading experts in artificial intelligence with focus on early GI neoplasia, but also other diseases. He is an expert in ESD and has been practising this technique since 2003 and now leads one of the largest centre using the technique in Europe. Professor Messmann was also involved in developing many guidelines of the European Society for Gastrointestinal Endoscopy as well as the Germany Society of Gastroenterology including bleeding guidelines.
He has published more than 300 peer reviewed articles and is editor of several books in interventional endoscopy, Gi oncology and Intensive care medicine.
Max NIEUWDORP
The University of Amsterdam’s Faculty of Medicine (AMC-UvA), The Netherlands
The Academic Medical Center’s Diabetes Unit and Laboratory for Expertimental Vascular Medicine, The Netherlands
The University of Gothenborg’s Wallenberg Laboratory, Sweden
The Netherlands
Max NIEUWDORP
The University of Amsterdam’s Faculty of Medicine (AMC-UvA), The Netherlands
Professor of Internal Medicine
Principal Investigator
The Academic Medical Center’s Diabetes Unit and Laboratory for Expertimental Vascular Medicine, The Netherlands
Director
The University of Gothenborg’s Wallenberg Laboratory, Sweden
Visiting Professor
Max Nieuwdorp has been appointed Professor of Internal Medicine, with a special focus on diabetes mellitus, at the University of Amsterdam’s Faculty of Medicine (AMC-UvA). Max Nieuwdorp works as an internist and endocrinologist at the AMC-UvA and conducts research into the role of intestinal bacteria in the development of diabetes, fatty liver (steatosis) and cardiovascular disease. Besides being the director of the Academic Medical Center’s diabetes unit and laboratory for Expertimental Vascular Medicine, Nieuwdorp also works as a diabetes researcher at the VU University Medical Center Amsterdam and is visiting professor at the University of Gothenborg’s Wallenberg laboratory. By making use of fecal transplants, Nieuwdorp investigates the causal role of intestinal bacteria that are involved in the emergence of the aforementioned diseases and whether it is possible to use specific treatment (by replenishing such bacterial strains through liquids or eliminate pathogens via vaccination) to influence, or even prevent, the course of these diseases. Nieuwdorp has been working at the AMC-UvA since 2012, where he has since then also become principal investigator. He is currently supervising a group of 12 PhD candidates and three postdoctoral researchers who are doing research on the issues mentioned above. Nieuwdorp is the recipient of various grants, including a 2014 Vidi grant from the Netherlands Organisation for Scientific Research (NWO), and forms part of several national (CVON) and international (FP7) research consortiums. In the coming period, Nieuwdorp will focus on the initiation of an Amsterdam diabetes centre, in which high quality care will be combined with translational research and teaching with the aim of decreasing levels of morbidity and mortality in this rapidly increasing number of patients.
Koji OTANI
Osaka Metropolitan University
Japan
Koji OTANI
Osaka Metropolitan University
Associate Professor, Department of Gastroenterology
Lecturer, Department of Gastroenterology
Koji Otani graduated from Medical Department of Osaka City University and qualified for M.D. in 2003. He started the training as a gastroenterologist since 2003. He graduated from Osaka City University Graduate School of Medicine and was awarded the title of Ph.D. in 2010. He studied at the Chinese University of Hong Kong under the instruction of Prof. Francis K.L. Chan and Prof. Jun Yu from 2012 to 2014. He was appointed an Associate Professor/Lecturer at the Department of Gastroenterology, Osaka City University Graduate School of Medicine in 2016, and is currently an Associate Professor/Lecturer at the Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine with the change of university name. His areas of expertise are Helicobacter pylori-induced gastritis, autoimmune gastritis, small bowel diseases, low-dose aspirin and non-steroidal anti-inflammatory drug-induced small intestinal damage, video capsule endoscopy and balloon-assisted enteroscopy, gut microbiota, and chronic constipation.
Nageshwar REDDY
Asian Institute of Gastroenterology, Hyderabad, India
AIG Hospitals, Hyderabad, India
India
Nageshwar REDDY
Asian Institute of Gastroenterology, Hyderabad, India
Chairman
AIG Hospitals, Hyderabad, India
Chairman
Nageshwar Reddy is currently the Chairman of Asian Institute of Gastroenterology and AIG Hospitals, Hyderabad, India. Past President of World Endoscopy Organization.
His main area of research interest has been in GI endoscopy and translational work in IBD, chronic liver diseases, and acute & chronic pancreatitis. He has published over 800 papers in national and international peer-reviewed journals and has contributed to multiple international textbooks of gastroenterology. He has received numerous awards, including the B C Roy Award from the Indian Medical Council in 1995, PADMA SHRI AWARD from the Government of India in 2002, PADMA BHUSHAN AWARD from the Government of India in 2016, ASGE International Leadership Award in 2011, Master of World Gastroenterology Organization from World Gastroenterology Organization in 2014 and Master Endoscopist Award from A.S.G.E in 2009. He also received fellowships from National Academy of Medical Sciences, New Delhi in 2001, American Association for the Advancement of Science (AAAS) and American Gastroenterological Association (FAGA) and American Gastroenterological Association (FAGA) in 2020, he was the honorary member for the American Society of Gastrointestinal Endoscopy in 2004. Additionally, he has received numerous other awards, including Rudolf Schindler award for gastrointestinal endoscopy (ASGE) 2021, Lifetime Achievement Award by GOVT of AP in 2022, AGA distinguished educator award 2021, Doctor of Science (D.Sc) Award by Institute of Liver & Biliary Sciences (ILBS) in 2022, WEO Lifetime Achievement award 2022, Inventor of ‘NAGI STENT’ and CHARAKA AWARD by Rotary Guindy, CHENNAI 2023.
Kewin SIAH
National University Hospital, Singapore
National University of Singapore
Singapore
Kewin SIAH
National University Hospital, Singapore
Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine
National University of Singapore
Assistant Professor, Department of Medicine
Clinical lecturer, Department of Medicine
Dr. Kewin Siah is a Gastroenterologist specialised in Functional Gastrointestinal Diseases (FGID). He completed his specialist training at National University Hospital and underwent further colonoscopy training at Kyoto Prefectural University of Medicine in Japan, as part of the JSGE research fellowship award. He also received the NMRC award to perform to study Irritable Bowel Syndrome (IBS) in Oppenheimer Neurobiology of Stress Centre in UCLA. He is currently running the Gastro Motility Lab and a multi-disciplinary IBS Clinic in NUH.
Dr. Siah is an Assistant Professor of the Department of Medicine, Yong Loo Lin School of Medicine. He has been regularly speaking at various local and regional conferences on FGID, and has had multiple publications in international peer-reviewed journals. He is now the Secretary General of Asian Neurogastroenterology and Motility Association, President of Singapore’s IBS Support Group and Executive Committee of National Foundation Digestive Disease.
Sunil Suhas SOLOMON
Johns Hopkins University School of Medicine
USA
Sunil Suhas SOLOMON
Johns Hopkins University School of Medicine
Professor of Medicine and Epidemiology in the Division of Infectious Diseases
Sunil Suhas Solomon is a Professor of Medicine and Epidemiology in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. He completed his medical training at the Sri Ramachandra Medical University in Chennai, India and received a Masters in Public Health and a doctorate in Epidemiology (PhD) from the Johns Hopkins University, USA. Dr. Solomon has been elected into the Phi Beta Kappa and the Delta Omega honors societies. His research is primarily focused on the epidemiology, prevention, clinical management and access to care for HIV and viral hepatitis among vulnerable populations including people who inject drugs and men who sex with men. He has been working with PWID in India since 2004 and has over 150 original peer-reviewed publications in several high-ranked journals. In 2015, he was one of the first recipients of the Avenir award, a Director’s award from the National Institutes of Health, USA aimed at identifying individuals who propose high impact research and who show promise of being tomorrow's leaders in the field of drug abuse and HIV. He also served as the Protocol Chair of ACTG5360 (MINMON) a Phase 4 multi-country trial designed to evaluate a minimal in-person monitoring protocol for the delivery of HCV treatment to people living with HCV globally findings of which are very relevant to the “new normal” we currently live in. He currently serves as the Protocol Chair of HPTN 103/PURPOSE4 a Phase 2 trial of long-acting PrEP among people who inject drugs (PWID). In April 2019, he was awarded a $35 million co-operative agreement from PEPFAR/USAID to implement and evaluate innovative models of service delivery to improve the HIV care cascade in India with a focus on vulnerable populations.
Jun SUN
University of Illinois at Chicago (UIC), USA
USA
Jun SUN
University of Illinois at Chicago (UIC), USA
Professor of Medicine
Associate Head of Department of Medicine
Jun Sun is a tenured Professor and Associate Head of Department of Medicine, the University of Illinois Chicago, USA. She is an elected Fellow for the American Physiological Society (APS) and American Gastroenterological Association (AGA) Fellow. She has chaired the AGA microbiome and microbial Therapy section from 2020-2022. Her research interests are host-microbiome interactions in inflammation, infection, and cancer. She is internationally known for her pioneering discovery of novel roles of microbiome in various human diseases, including vitamin D deficiency, amyotrophic lateral sclerosis (ALS), infection, and cancer. She chairs the national Task Force Committee on Omics Pathobiology in Long COVID and writes white papers on COVID and microbiome research. Her key achievements include 1) characterization of vitamin D receptor regulation of intestinal barrier and microbiome in inflammation and cancer, 2) identification of dysbiosis and intestinal dysfunction in ALS, and 3) characterization of bacteria in regulating intestinal stem cells and leading to cancer. Dr. Sun has published over 220 scientific articles in leading journals such as Gastroenterology, Gut, Cell Stem Cell, Nature Genetics, Gut Microbes, JBC, and AJP-GI. She is the leading editor of 9 books on microbiome and disease, including two American Physiological Society (APS) e-books (Nature/Spring) titled “Mechanisms underlying host-microbiome interactions in pathophysiology of human diseases” and “Inflammation, infection, and microbiome in cancers: evidence, mechanisms, and implications”. She serves on the editorial board of high-impact peer-reviewed journals, including a Deputy Editor for American Journal of Physiology-GIL, an Associate Editor for Gut Microbes, IBD Journal, and Genes & Diseases, She services study sections for the NIH, DOD, NASA, CCF, American Cancer Society, and other research foundations. Her research is supported by the NIH, DOD, and VA awards.
Raymond TANG
The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Hong Kong
Hong Kong
Raymond TANG
The Chinese University of Hong Kong, Hong Kong
Director, S.H. Ho Center for Digestive Health
Assistant Professor, Department of Medicine and Therapeutics
Prince of Wales Hospital, Hong Kong
Deputy Director, Endoscopy Center
Raymond Tang received his M.D. degree from University of Southern California, Keck School of Medicine in 2004 and was selected to the Alpha Omega Alpha Honor Medical Society. He completed his internal medicine residency at University of California, Los Angeles Medical Center in 2007. He completed his gastroenterology and hepatology fellowship at University of California, San Diego Medical Center and achieved certification in gastroenterology from the American Board of Internal Medicine in 2010. Dr. Tang subsequently pursued training in advanced endoscopy with focus on EUS, ERCP and balloon-assisted enteroscopy at University of California, San Diego Medical Center in 2010 - 2011.
His clinical and research interests include advanced diagnostic and interventional EUS, ERCP, device assisted enterocsopy, and pancreatic cystic neoplasms. He has published papers and written book chapters on topics of EUS, ERCP, pancreatic cystic neoplasms and GI bleeding.
Dr. Tang is currently an Assistant Professor at the Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Deputy Director of endoscopy center at the Prince of Wales Hospital, and Director of the S.H. Ho Center for Digestive Health.
Anthony TEOH
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Anthony TEOH
The Chinese University of Hong Kong, Hong Kong
Deputy Director of Endoscopy
Professor, Department of Surgery
Anthony Teoh is currently the Deputy Director of Endoscopy and Professor in The Chinese University of Hong Kong. He is current the Chairman of the WEO research subcommittee, Vice president of the Asian EUS group and the Hong Kong Hernia Society. He also serves as Secretary to the Hong Kong EUS society. He is also a council member of the Hong Kong College of Surgeons, Hong Kong Hernia society, Hong Kong society of Robotic surgery and Hong Kong Society of Digestive Endoscopy. He graduated from the Chinese University of Hong Kong in 2001. After completing his surgical training, he has received overseas training in many international centres including the Kitasato University East Hospital and the Cancer Institute Hospital (Ariake) in Japan, the University of Washington, Cornell University and Stanford University in USA. His research interests are multifold and these include advanced interventional endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiography (ERCP), minimally invasive upper gastrointestinal cancer surgery, hernia surgery and robotics surgery. He is a winner of multiple awards including 2019 Asian Pacific Digestive Week Emerging Leaders Lectureship, Carlos Pellegrini Traveling Fellow, American Society for Gastrointestinal Endoscopy endoscopic research awards, the GB Ong and Li Shield’s Medal (best candidate in the fellowship examinations both locally and internationally). He has served as a Visiting Professor to the Stanford Medical Center, Fujian University Medical Hospital, Consultant for Hepatopancreatobiliary Minimally Invasive Surgery Institute of Central South University. He is also a steering committee member for the Asian EUS group, member of pancreaticobiliary committee of the World Endoscopy Organization, council member of the Hong Kong College of Surgeons, Hong Kong Hernia society, Hong Kong society of Robotic surgery and Hong Kong Society of Digestive Endoscopy. In addition, he is currently an Associate Editor for Gastrointestinal Endoscopy, Digestive Endoscopy, Endoscopy International Open and Techniques in Gastrointestinal Endoscopy. His other editorial board experiences include several internationally renowned journals: Clinical gastroenterology and hepatology, VideoGIE, Endoscopic ultrasound, Saudi journal of gastroenterology, World journal of Gastrointestinal endoscopy and World Journal of Gastroenterology. He has obtained over $10 million HKD in research grants, published over 150 journal papers and written 14 book chapters. He is currently a Consultant for Boston Scientific, Cook, Taewoong, Microtech and M.I. Tech Medical Corporations.
Alexander THOMPSON
University of Melbourne, Australia
Australia
Alexander THOMPSON
University of Melbourne, Australia
Director, Department of Gastroenterology
Alexander Thompson is a Director of the Department of Gastroenterology at St Vincent’s Hospital and the University of Melbourne, Australia, NHMRC Practitioner Fellow and Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Center. Professor Thompson is the lead hepatologist for the Statewide Prison Hepatitis Service in Victoria, Australia. He is a current board member of the Gastroenterology Society of Australia, and former executive council member of the Asia Pacific Association for the Study of the Liver.
His research focusses on improving outcomes for people living with viral hepatitis. He was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV, and is an active clinical investigator for trials evaluating the efficacy of novel antiviral DAA regimens. With the development of DAA therapy for HCV, he has more recently been actively pursuing the development and evaluation of new models of care for people with HCV, with a focus on prisoners and treatment as prevention to eliminate transmission and reduce prevalence of HCV in Australia.
Professor Thompson has published widely in journals including Nature, New England Journal of Medicine, Journal of the American Medical Association, Gastroenterology, Hepatology, Gut and Journal of Hepatology.
Michael VIETH
Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth, Germany
Germany
Michael VIETH
Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth, Germany
Head of Institute of Pathology
Michael VIETH has joined Institute of Pathology, Klinikum Bayreuth in Germany since Dec 2004. He was a consultant and then was promoted as Director of the Department in October 2007, and currently he is the Head of Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth in Germany since 2008.
He was a Consultant, Institute of Pathology at the University of Magdeburg in January 2003 and received his habitation and second PhD in General and Surgical Pathology at the University of Magdeburg in June 2004.
Professor Vieth is the member of International Academy of Pathology, International Working Group of classification of esophagitis, German Society of Pathology, Subgroup of gastrointestinal Pathology, German Association of Pathologists, American Society of Gastroenterology, American Society of Surgical Pathology, American Society of Gastrointestinal Pathology, German Society of Endoscopy and Imaging techniques, German Society of Gastrointestinal disorders and Academia Europaea. He has co-authored more than 600 publications.
Dennis WONG
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Dennis WONG
The Chinese University of Hong Kong, Hong Kong
Research Assistant Professor, Department of Medicine and Therapeutics
Dennis Wong obtained his BSc (2003-2005) and M.Phil. (2005-2007) degrees from the University of Hong Kong, before pursuing a Ph.D. in the University of Leeds, UK in 2008 and graduating in 2011. After two and a half years of postdoctoral training at Stony Brook University, NY, USA, Dr. Wong joined the Chinese University of Hong Kong in October, 2013, as Research Assistant Professor in the Department of Medicine and Therapeutics and a member of the State Key Laboratory of Digestive Disease. His research interests are primarily in the field of gastrointestinal cancers, trying to understand their molecular basis and develop therapeutic approaches to inhibit tumorigenesis, ultimately contributing to improved patient care. He has published over 78 papers in peer-reviewed international journals including Gastroenterology, Science Translational Medicine, Cancer Research, Oncogene and Seminars in Cancer Biology. He has also been invited to speak in national and international conferences, including the Digestive Disease Week and United European Gastroenterology Week. His work is supported by external competitive grants from the Research Grant Council-General Research Fund (RGC-GRF), Health and Medical Research Fund (HMRF), National Natural Science Foundation of China (NSFC).
Grace WONG
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Grace WONG
The Chinese University of Hong Kong, Hong Kong
Director, Medical Data Analytics Centre (MDAC)
Deputy Director, Center for Liver Health
Assistant Dean (Learning Experience), Faculty of Medicine
Professor, Department of Medicine and Therapeutics
Grace Wong is the Professor of The Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong in 2001 with honors and distinctions in Medicine. In 2010, she received the Doctorial Degree of Medicine of the Chinese University of Hong Kong.
Grace Wong’s main research interest includes big data research in hepatology, chronic viral hepatitis, and risk prediction and risk reduction of hepatocellular carcinoma, and non-invasive assessment of liver fibrosis. She has published over 390 articles in peer-reviewed journals including Lancet Gastroenterology and Hepatology, Journal of Hepatology. Gastroenterology and Gut. She is currently the editor-in-chief of Hepatology (Hong Kong edition), the associate editor of Alimentary Pharmacology and Therapeutics and Journal of Gastroenterology and Hepatology. She has been awarded for the Young Investigator Award of the Asian Pacific Association for the Study of the Liver in 2009, the Distinguished Research Paper Award for Young Investigators of the Hong Kong College of Physicians in 2010, 2013, 2014 and 2015, the Ten Outstanding Young Persons (TOYP) of Hong Kong in 2014, the Distinguished Young Fellow of Hong Kong Academy of Medicine in 2017, the Emerging Leader Lectureship of the Journal of Gastroenterology and Hepatology Foundation (JGHF), the Presidential Awards in the Global Hepatitis Summit 2021, the Richard Yu Lectureship of Hong Kong College of Physicians in 2021, and the Best Reviewer Award of the Journal of Hepatology in 2022.
Marc WONG
Prince of Wales Hospital, Hong Kong
Hong Kong
Marc WONG
Prince of Wales Hospital, Hong Kong
Associate Consultant, Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics
Marc Wong graduated from the Li Ka Shing Faculty of Medicine, the University of Hong Kong in 2009, receiving two scholarships and the Woo Kai Fun Prize. He completed his training in Gastroenterology and Hepatology in 2016 before joining the Department of Medicine and Therapeutics, Prince of Wale Hospital as a Resident Specialist in 2018. Dr Wong is currently Associate Consultant of Department of Medicine and Therapeutics at Prince of Wales Hospital and in charge of the Motility services in Prince of Wales Hospital, with special focus on oesophageal motility disorders and gastro-oesophageal reflux disease (GERD). His work includes collaboration with the Flinders University, Australia on pharyngeal manometry and is the first in Asia to have performed the FLIP topography using the EndoFLIP 2.0 system. Marc also has strong interest in advanced endoscopy including EUS and ERCP. He has been nominated for various international Train-the-Trainer Courses on EUS.
Martin WONG
The Chinese University of Hong Kong
Hong Kong
Martin WONG
The Chinese University of Hong Kong
Professor, JC School of Public Health and Primary Care, Faculty of Medicine
Professor (by courtesy), Department of Sports Science and Physical Education
Martin Wong is a specialist in Family Medicine and a researcher in the field of cancer screening and prevention of chronic diseases. Professor Wong has composed over three hundred publications in international peer-reviewed journals, and received over 15 research awards for studies in his research area, including the prestigious “1st Distinguished Research Making Family Medicine Shine Award” by the World Organization of Family Doctors in 2018. He is the Co-Chair of the NCD stream of APRU Global Health Programme; Co-Chairman of the Grant Review Board, Health and Medical Research Fund, Food and Health Bureau (FHB); the Convener of the Advisory Group on Hong Kong Reference Framework for Care of Diabetes and Hypertension in Primary Care Settings; a member of the Expert Advisory Panel in Implementation Science of the HKSAR government, and a member of the Research Council of the FHB. He is a reviewer of the Medical Research Council (MRC), United Kingdom; expert reviewer of the National Medical Research Council (NMRC), Singapore; external examiners of doctoral thesis in various Universities; and an external reviewer of the Public Policy Research Funding Scheme, Research Grant Council (RGC) of Hong Kong. His enthusiasm to teaching has been well received by students and has been selected for the “Master Teacher” and the “Annual Teacher of the Year Award” for seven years.
In 2016, he was conferred as an Honorary Fellow by the Hong Kong Academy of Nursing to recognize his achievements in the profession and contributions to primary care. He was appointed as the Editor-in-Chief of the Hong Kong Academy of Medicine in 2017; and Fellows of various Academies, Royal Colleges and professional societies. He is currently taking adjunct appointments as Professor of the Peking Union Medical College in March 2019; Professor of Global Health by the Peking University, and Professor of Public Health in the Fudan University.
Robert WONG
Stanford University School of Medicine, USA
Veterans Affairs Palo Alto Healthcare System, USA
USA
Robert WONG
Stanford University School of Medicine, USA
Clinical Associate Professor, Medicine in the Division of Gastroenterology and Hepatology
Veterans Affairs Palo Alto Healthcare System, USA
Staff Physician
Robert Wong is a Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, Stanford University School of Medicine, and staff physician at the Veterans Affairs Palo Alto Healthcare System. His clinical interests include management of patients with complex liver diseases, including viral hepatitis, hepatocellular carcinoma, and nonalcoholic fatty liver disease. His research focuses on epidemiology, outcomes, and health services research in patients with chronic liver diseases, with a particular focus on healthcare disparities among under-served, vulnerable, and ethnic minority populations. His research has been funded by the National Institutes of Health, the American Association for the Study of Liver Diseases, the American College of Gastroenterology, and others. His work has been published in high impact journals including, JAMA, American Journal of Medicine, Hepatology, Gastroenterology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology. He serves on the editorial board of Hepatology and Journal of Clinical Gastroenterology, and he is the current editor-in-chief of Gastroenterology Research. He is the current President of the Northern California Society of Clinical Gastroenterology.
Sunny WONG
Nanyang Technological University, Singapore
Singapore
Sunny WONG
Nanyang Technological University, Singapore
Associate Professor at the Lee Kong Chian School of Medicine
Sunny Wong is an Associate Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. He received his MBChB at the Chinese University of Hong Kong, and his PhD in University of Oxford on genetics of bacterial infections. He completed his clinical training in gastroenterology in the Prince of Wales Hospital in Hong Kong. His main research interest is on gut microbiome, investigating the host-microbe interaction in digestive and metabolic diseases, and exploring this for discovery of novel biomarkers and therapeutics. He has won several awards, including the Asia Pacific Digestive Week Emerging Leaders Lectureship (2021), the Hong Kong College of Physicians Sir David Todd Lectureship (2020) and the Croucher Foundation Award (2014). He has published over 200 peer-reviewed articles including papers in Nature Genetics, Nature Communications, Gastroenterology and Gut, and is currently an Associate Editor for the Journal of Gastroenterology and Hepatology.
Vincent WONG
The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Hong Kong
Hong Kong
Vincent WONG
The Chinese University of Hong Kong, Hong Kong
Professor, Department of Medicine & Therapeutics
Head, Division of Gastroenterology and Hepatology, Faculty of Medicine
Prince of Wales Hospital, Hong Kong
Honorary Consultant
Vincent Wong is Mok Hing Yiu Professor of Medicine at the Division of Gastroenterology and Hepatology, The Chinese University of Hong Kong. His research focuses on viral hepatitis and non-alcoholic fatty liver disease (NAFLD), in particular the use of non-invasive tests for screening and diagnosis. He has authored over 500 articles in international medical journals, and his latest h index is 91. Together with the Asia-Pacific Working Party, he wrote the Asia-Pacific Guidelines on the Management of NAFLD in 2018. He is an associate editor of Alimentary Pharmacology and Therapeutics and an editorial board member of the Journal of Hepatology, Hepatology, JHEP Reports and Hepatology Communications. He served as the president of the Hong Kong Association for the Study of Liver Diseases from 2015 to 2017. His team received research awards from the Asian Pacific Association for the Study of the Liver, Asian Pacific Digestive Week Federation, British Society of Gastroenterology, Hong Kong College of Physicians and the Food and Health Bureau.
Chun-ying WU
Taipei Veterans General Hospital, Taiwan
National Yang-Ming University, Taiwan
National Institute of Cancer Research, Taiwan
Tunghai University, Taiwan
Taiwan
Chun-ying WU
Taipei Veterans General Hospital, Taiwan
Director, Translational Research
Professor, Gastroenterology
National Yang-Ming University, Taiwan
Professor, Graduate Institute of Clinical Medicine
National Institute of Cancer Research, Taiwan
Joint Appointment Researcher
Tunghai University, Taiwan
Professor, College of Law
Chun-Ying Wu received his M.D. degree from the National Taiwan University (NTU) in 1991, M.P.H. degree from Harvard School of Public Health in 1993, and Ph.D. degree from NTU in 2007. Prof. Wu has positions as the Director of Translational Research and Professor of Gastroenterology in Taipei Veterans General Hospital, Joint Appointment Researcher of National Institute of Cancer Research, and also Professor of Graduate Institute of Clinical Medicine, including National Yang-Ming University (NYMU). Prof. Wu establishes Taiwan Microbiome Consortium and currently serves as the first President in the consortium. Prof. Wu is now the Editor-in-Chief of Advances in Digestive Medicine (the joint official journal of GEST, DEST & TASL), editorial member of Gut, Vice-Secretary General of both the Gastroenterological Society of Taiwan and the Digestive Endoscopy Society of Taiwan, the executive of the Taiwan Liver Cancer Association, and the control board of the Taiwan Evidence-based Medicine Association. Prof. Wu has published many articles in top ranking journals such as JAMA, J Clinical Oncology, Gastroenterology, Gut, Hepatology, etc. Prof. Wu owns several patterns, including gastric cancer screening and hepatitis B virus quantitative detection. Prof. Wu is the winner of National Innovation Award 2016, Taiwan Institute for Biotechnology & Medicine Industry; Outstanding Research Award 2015, Taiwan’s Ministry of Science and Technology; and Emerging Leadership Award 2015, Asia-Pacific Digestive Week. Prof. Wu also got several Best Teaching Awards from NYMU.
Prof. Wu is also very active in legal societies. He received his LL.B. degree from Tunghai University (TU) in 2000 and LL.M. degree from Harvard Law School in 2003. He is the current President of Taiwan Society of Law and Medicine and Professor of Law in College of Law at the TU. He is also the member of Medical Dispute Assessment Committee of Ministry of Health and Welfare (MOHW), the member of Institute Review Board of the National Health Research Institutes (NHRI), the member of the Ethical Committee of many central governments’ departments, including MOHW and NHRI. His legal research interests include medical malpractice litigation and biotechnology regulation. Prof. Wu has published four law textbooks, four chapters in law books, and more than 60 articles in peer-reviewed journals. Prof. Wu’s evidence-based research has become the important basis of many Taiwan’s nationwide policies regarding medical malpractice.
Gary WU
The University of Pennsylvania, USA
USA
Gary WU
The University of Pennsylvania, USA
Ferdinand G. Weisbrod Professor, Gastroenterology, Perelman School of Medicine
Director, Center for Molecular Studies in Digestive and Liver Diseases
Director, Penn Center for Nutritional Science and Medicine
Co-Director, PennCHOP Microbiome Program
Gary Wu, MD is the Ferdinand G. Weisbrod Professor in Gastroenterology at the University of Pennsylvania’s Perelman School of Medicine. He is the Director for Basic Research in the Division of Gastroenterology and Hepatology, Director of both the NIH Center for Molecular Studies in Digestive and Liver Disease and the Penn Center for Nutritional Science and Medicine as well as the Co-Director of both the PennCHOP Microbiome Program. He was the inaugural Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association’s Center for Gut Microbiome Research and Education and is an elected member of both the American Society for Clinical Investigation and the Association of American Physicians. Research in the Wu lab currently focuses the impact of diet on the gut microbiome and its relationship to several aspects of host metabolism including nitrogen balance, intestinal oxygen regulation, and epithelial intermediary metabolism.
Peter WU
St George Hospital, Sydney, Australia
Australia
Peter WU
St George Hospital, Sydney, Australia
Director, Motility Services
Peter Wu graduated in Medicine from the University of New South Wales in 2006 and completed his training in adult gastroenterology in 2014. He was awarded a PhD in 2018 for thesis where he investigated several novel diagnostic and therapeutic tools in the management of swallowing disorders. In 2019, Peter undertook a fellowship at Prince of Wales Hospital, Hong Kong, where he developed advanced therapeutic endoscopic skills with a focus in the third space endoscopy. During the same year, he commenced several ongoing international collaborative research projects evaluating novel therapeutic procedures as treatment for dysphagia. Peter currently works at St George Hospital, Sydney, where he serves as the director of the St George Motility Services, overseeing the clinical operation of the Swallow Clinic and GI Motility Laboratory.
Hon-chi YIP
The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Hong Kong
Hong Kong
Hon-chi YIP
The Chinese University of Hong Kong, Hong Kong
Clinical Assistant Professor, Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery
Prince of Wales Hospital, Hong Kong
Honorary Associate Consultant
Hon-chi Yip is currently Clinical Assistant Professor at the Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong. He is also serving as honorary associate consultant at the Prince of Wales Hospital.
Dr. Yip graduated from the Chinese University of Hong Kong in 2008 with honors. He received the RC Li Gold Medal in Surgery. He joined the Department of Surgery at Prince of Wales Hospital after graduation and obtained the fellowship in General Surgery in 2015.
Focusing on Upper Gastrointestinal Tract Cancer management, Dr. Yip underwent overseas training in Osaka and Tokyo, Japan in 2017. His current research focuses on endoscopic diagnosis and treatment of early gastrointestinal cancer, as well as minimally invasive techniques in surgical treatment of gastric and esophageal neoplasia.
Dr. Yip is engaged in regional education and training. He serves as a core member in the Asian Novel Bio-imaging and Intervention Group (ANBIIG), an Asian wide organization focusing on endoscopic diagnosis and treatment of GI luminal diseases. He is also a member of the Education Committee in the Asia-Pacific Society of Digestive Endoscopy (APSDE). He is currently board member of the Asia-Pacific Endo-Laparoscopic Surgery Group (APELS).
Terry YIP
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Terry YIP
The Chinese University of Hong Kong, Hong Kong
Assistant Professor, Department of Medicine and Therapeutics
Terry Yip is an Assistant Professor in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong. Terry’s research interest is big data approaches and risk prediction in patients with chronic liver diseases. He has over 130 publications in peer-reviewed journals including Gastroenterology, Gut, Journal of Hepatology, and Hepatology. He received the Young Investigator Award in 2018, 2022, and 2023 at the APASL meeting, and the Early Career Investigator Award in Clinical/Translational Science in 2020 at the AASLD meeting. He is now an Associate Editor of the Journal of Hepatology, Frontiers in Gastroenterology - Hepatology, and Frontiers in Medicine - Hepatobiliary diseases; and an Editorial Board member of Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Hepatology Communications, and Hepatoma Research.
Chang-hoon YOO
University of Ulsan College of Medicine, Korea
Korea
Chang-hoon YOO
University of Ulsan College of Medicine, Korea
Associate Professor, Department of Oncology, Asan Medical Center
Chang-hoon YOO is a medical oncologist who specializes in the care of patients with gastrointestinal cancers, particularly, pancreatic cancer, cholangiocarcinoma, hepatocellular carcinoma and neuroendocrine tumors. He has participated in multiple clinical trials and translational research for the development of novel agents for patients with these cancers and has authored and co-authored more than 110 research articles. His research initiatives include the integration of novel targeted and immune-based therapy into the treatment of hepatobiliary-pancreas cancers, and neuroendocrine tumors
Jun YU
The Chinese University of Hong Kong, Hong Kong
Hong Kong
Jun YU
The Chinese University of Hong Kong, Hong Kong
Choh-Ming Li Professor of Medicine and Therapeutics
Assistant Dean, Faculty of Medicine
Director, Institute of Digestive Disease
Director, State Key Laboratory Digestive Disease
Jun Yu serves as Council Member of American Gastrointestinal Association (AGA) Oncology (2017-2018) and Council Member of AGA Microbiome and Microbial Diseases (2018-2021), USA; 中國醫學科學院學部委員；Vice-Chairman of Cancer and Gut Microbiome of Anti-Cancer Association China; Vice-Chairman of China Women Physicians Association (GI session). Her research interests being molecular pathogenesis, microbiome, diagnostic biomarkers and therapeutic targets of gastrointestinal cancers and fatty liver disease. She has over 550 peer-reviewed publications (201 papers IF>10; 95 papers with IF > 30; ISI citation >33,200, ISI h-index=95; Google Scholar citation 54302, h-index 116). She obtained over 50 prestigious awards including The National Natural Science Award (2020 and 2016); Guanghua Engineering Science & Technology Prize China (2022); Top 10 Scientists in Global Gut Microbiome Study (2019); He Liang He Li Science and Technology Progress Award (2018); AGA Council Research Mentor Award (2017); WuXi PharmaTech Life Science Award (2017); Croucher Senior Research Fellowship (2016); State Science and Technology Progress Award (2012). She is ranked top 3 in China and 162 in the world of the top 1000 female researchers in 2022 (Research.com).
Close
